VXL-301
/ Vaxil Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 10, 2020
Vaxil applies for coronavirus vaccine patent under its anti-infective vaccines platform and provides update on the exercise of warrants
(GlobeNewswire)
- "VAXIL BIO LTD...announces that it has submitted a new patent application for its anti-infective vaccines platform as a result of our recently announced COVID19 candidate discovery....Vaxil has applied for a US patent (U.S 62/987,310) on a coronavirus vaccine that is intended to provide broad patent protection for novel vaccines, pharmaceutical compositions and methods of treating and preventing an infectious disease as well as methods for producing a peptide vaccine against coronaviruses."
Patent
1 to 1
Of
1
Go to page
1